More than 17-thousand patients took part in the major five-year study by University College London.
New research suggests the weight loss drugs Ozempic and Wegovy also reduce the risk of heart attacks and strokes.
The injections were found to lower risks of cardiovascular diseases by a fifth - even in patients whose weight stayed the same.
More than 17-thousand patients took part in the major five-year study by University College London.
However Obesity Lead with the HSE Dr. Donal O'Shea says the jabs are not the end of obesity.